|03/02/17||Accuray Launches New Cancer Patient Websites|
|SUNNYVALE, Calif., March 2, 2017 /PRNewswire/ -- The Internet is one of the first places patients turn to for healthcare information after receiving a cancer diagnosis, according to the American Cancer Society. Accuray Incorporated (NASDAQ: ARAY) is launching www.cyberknife.com and www.tomotherapy.com to provide an additional resource for cancer patients to turn to for information about their disease and potential treatment options. Enhanced functionality and ease-of-use puts the information pat... |
|02/21/17||Accuray to Present at Cowen and Company 37th Annual Healthcare Conference on March 6, 2017|
|SUNNYVALE, Calif., Feb. 21, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), announced today that the Company will present at Cowen and Company's 37th Annual Healthcare Conference in Boston on Monday, March 6, 2017.
Accuray's fireside chat with analyst Joshua Jennings, M.D. will begin at 2:40 p.m. ET and be webcast live on the Investor Relations page of the Company's website at http://www.accuray.com/investors. A replay of the webcast will be availa... |
|02/16/17||CyberKnife® System Provides Long-term Disease Control for Prostate Cancer Patients|
|Prospective, Multi-institutional Study Shows CyberKnife SBRT Treatment Results in Low PSA Nadir for Low- and Intermediate-risk Prostate Cancer Patients
SUNNYVALE, Calif., Feb. 16, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today data from a prospective, Phase II, 17-center study which showed that treatment with the CyberKnife® System for low- and intermediate-risk prostate cancer provides excellent long-term results. At five years, the disease-free survival rate for... |
|02/13/17||Accuray to Participate in the 2017 RBC Capital Markets Healthcare Conference on February 22, 2017|
|SUNNYVALE, Calif., Feb. 13, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), announced today that Kevin Waters, Senior Vice President and Chief Financial Officer, is scheduled to meet with investors one-on-one at the 2017 RBC Capital Markets Healthcare Conference in New York on Wednesday, February 22, 2017.
Attendance at the conference is by RBC Capital Markets invitation only. The investor presentation used at the conference will be available on ... |
|02/08/17||The Accuray Radixact™ System Receives Shonin Approval|
|Next-Generation "Smart" TomoTherapy® System Represents Major Step Forward in Treatment Speed, Ease of Use and Adaptive Therapy Capabilities
SUNNYVALE, Calif., Feb. 8, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that it has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its Radixact™ Treatment Delivery System, Accuray Precision™ Treatment Planning System and iDMS™ Data Management System. Together, the treatment d... |
|01/31/17||Accuray Grows Second Quarter Gross Orders 17%; Backlog Up 16% YoY|
|SUNNYVALE, Calif., Jan. 31, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the second fiscal quarter and six months ended December 31, 2016.
Fiscal Second Quarter Highlights
Ending backlog increased 16 percent year-over-year to $426.2 million; gross orders were $78.5 million with net orders of $54.1 million
Strong mix of CyberKnife® System orders; greater than 70% equipped with the InCise™ Multileaf Coll... |
|01/26/17||Miami Cancer Institute Treats First Cancer Patients with the Accuray Radixact™ System|
|Day 1 Experience Demonstrates the Speed and Efficiency of the New System
SUNNYVALE, Calif., Jan. 26, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Miami Cancer Institute, a part of Baptist Health South Florida, is now treating patients using the new, uniquely "smart" Radixact™ Treatment Delivery System, fully integrated with the new Accuray Precision™ Treatment Planning System and iDMS™ Data Management System. Miami Cancer Institute selected the Radixact plat... |
|01/19/17||Accuray Continues to Set the Industry Standard for Customer Satisfaction|
|MD Buyline Report Shows Composite Overall User Satisfaction Ratings Exceed Industry Average for 14 Consecutive Quarters
SUNNYVALE, Calif., Jan. 19, 2017 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that its CyberKnife® and TomoTherapy® Systems continue to set the bar for excellence in customer satisfaction. The Accuray systems received the highest composite overall user satisfaction rating among radiation treatment delivery systems in the U.S., according to the Q4 201... |
|01/17/17||Accuray To Report Fiscal 2017 Second Quarter Financial Results On January 31, 2017|
|SUNNYVALE, Calif., Jan. 17, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal second quarter ended December 31, 2016 on Tuesday, January 31, 2017 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day.
The conference call dial-in numbers are 855-867-4103 (USA) or 262-912-4764 (International). In addition, a dial up replay of the conference cal... |
|01/10/17||Accuray to Present at JP Morgan's 35th Annual Healthcare Conference on January 11, 2017|
|SUNNYVALE, Calif., Jan. 10, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will present at JP Morgan's 35th Annual Healthcare Conference on Wednesday, January 11, 2017 at the Westin St. Francis Hotel in San Francisco.
Accuray's presentation will begin at 11:30 a.m. PT and a webcast with accompanying slides will be available on the Investor Relations page of the Company's website at http://www.accuray.com/investors. ... |